GCC Organ Preservation Market

ID: MRFR/HC/47701-HCR

200 Pages

Garvit Vyas

September 2025

GCC Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End User (Hospitals & Clinics, Organ Banks) - Forecast to 2035

GCC Organ Preservation Market -Forecast to 2035 Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

GCC Organ Preservation Market Summary

The GCC Organ Preservation market is projected to grow significantly from 17 USD Million in 2024 to 103 USD Million by 2035.

Key Market Trends & Highlights

GCC Organ Preservation Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 17.79% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 103 USD Million, indicating robust growth potential.
In 2024, the market is valued at 17 USD Million, reflecting the initial stages of development in organ preservation technologies.
Growing adoption of advanced preservation techniques due to increasing organ transplant demand is a major market driver.

GCC Organ Preservation Market

CAGR

17.79%

Market Size & Forecast

2024 Market Size	17 (USD Million)
2035 Market Size	103 (USD Million)
CAGR (2025-2035)	17.79%

Major Players

Bellicum Pharmaceuticals, TransMedics, Alliance BioEnergy, Paragonix Technologies, United Therapeutics, Abbott Laboratories, CellTrans, Baxter International, Thermo Fisher Scientific, LifeNet Health, Haemonetics Corporation, Xvivo Perfusion, Celsion Corporation, Organ Recovery Systems, LifeShare

GCC Organ Preservation Market Trends

The GCC Organ Preservation Market is witnessing several important trends that are shaping its future. The region's growing investment in healthcare infrastructure is significantly enhancing organ preservation technologies. Governments across the GCC are focusing on improving their healthcare systems, which includes the development of advanced organ preservation solutions.

This approach aligns with the increasing number of organ transplant surgeries being performed as more patients seek successful outcomes through well-preserved organs. A notable trend is the adoption of innovative preservation techniques, such as hypothermic preservation and machine perfusion, which are supported by local research institutions and hospitals.

With rising awareness about organ donation and transplantation, there is a growing public interest in organ preservation. This trend is being fueled by various campaigns led by health ministries in the GCC, promoting the importance of organ donation and its impact on saving lives.

The region's demographic shifts, including an aging population and a rise in chronic diseases, highlight an immediate need for efficient organ preservation methods to support transplant programs. Opportunities are present for local companies to collaborate with international players to enhance their capabilities in organ preservation technologies.

By focusing on education and training initiatives, the GCC can build a workforce skilled in organ preservation practices. Additionally, leveraging regional research capabilities to innovate and adapt preservation techniques can lead to improved transplant outcomes.

Overall, the GCC Organ Preservation Market is poised for growth with a clear shift towards advanced technologies, increased public engagement, and supportive government policies driving the industry forward.

Market Segment Insights

Organ Preservation Market Solution Insights

The GCC Organ Preservation Market's Solution segment is integral to advancing transplant surgery and organ donation efficiencies, focusing on optimizing the preservation of organs for transplantation. As healthcare systems in the GCC region evolve, the demand for effective organ preservation solutions continues to rise, driven by increasing transplant volumes and the growing need for organ viability during transport.

University of Wisconsin Solution is widely acknowledged for its efficacy in preserving various organs, particularly kidneys.Custodial HTK presents a notable alternative with a unique composition designed for optimal heart and liver preservation.Collins Solution is beneficial for both kidney and liver preservation, offering advantages in terms of reducing cellular injury during cold storage.

Celsior Solution, known for its oxygen-carrying capacity, enhances organ viability for extended periods and is essential in regions where transportation times are increased. Perfadex is tailored for preserving lungs, where maintaining optimal conditions for organ viability is paramount, reflecting the particular challenges of lung transplantation.

Citrate Solution, recognized for its ability to stabilize organs at low temperatures, provides an additional option for preserving organs efficiently during the critical stage of transport. The GCC region's healthcare infrastructure is advancing through investments in organ transplantation technologies, and these solutions play crucial roles in enhancing organ preservation techniques.

These advancements ultimately contribute to improved patient outcomes and transplant success rates. The market exhibits substantial growth potential as healthcare providers increasingly prioritize the adoption of these advanced preservation techniques, representing a dynamic area for development and innovation within the broader context of the GCC Organ Preservation Market.

Organ Preservation Market Preservation Techniques Insights

The Preservation Techniques segment within the GCC Organ Preservation Market plays an essential role in ensuring the viability and efficacy of organ transplantation. Notably, methods such as Static Cold Storage and Dynamic Cold Storage are critical for maintaining organ quality during transport.

Static Cold Storage remains widely utilized for its simplicity and effective cooling capabilities, preserving organs at lower temperatures to inhibit metabolic processes. Dynamic Cold Storage is emerging as a significant alternative, offering enhanced protection through continuous perfusion, which supplies nutrients and oxygen to the organ, thereby extending its preservation time.

The growing number of transplant procedures across the GCC region and the increasing emphasis on organ donation are key drivers behind the demand for advanced preservation techniques. Furthermore, supported by government initiatives aimed at improving healthcare infrastructure and public awareness of organ donation, the market is positioned for robust growth.

These preservation techniques ensure that donated organs remain viable for transplantation, significantly impacting patient outcomes and the overall efficiency of healthcare systems in the GCC. Both Static and Dynamic Cold Storage methods represent critical progress in organ preservation, reflecting advancements in medical technology and enhanced patient care strategies.

Organ Preservation Market Organ Type Insights

The GCC Organ Preservation Market is experiencing significant growth, propelled by advancements in medical technology and increasing demand for organ transplants. The market is notably segmented by Organ Type, which includes critical organs such as Kidney, Liver, Heart, and Lungs.

Kidney preservation segment is particularly vital due to the high prevalence of kidney diseases and the need for effective preservation methods. Liver preservation is gaining attention because of the rise in liver-related ailments, prompting innovative preservation techniques. Heart preservation is also a focal point, as the growing number of cardiovascular disorders emphasizes the necessity for efficient heart transplant procedures. Lungs are becoming increasingly prioritized due to an uptick in pulmonary diseases and the need for optimal conditions.

The increasing awareness of organ transplantation and improvements in preservation techniques are driving the overall demand in the GCC region. This provides ample opportunities for market players to innovate and meet growing healthcare needs. The GCC Organ Preservation Market revenue reflects these evolving dynamics, fueled by regulatory support and increased investments in healthcare infrastructure.

Organ Preservation Market End User Insights

The End User segment of the GCC Organ Preservation Market plays a crucial role in the overall ecosystem, primarily encompassing Hospitals and Clinics, as well as Organ Banks. Hospitals and Clinics are pivotal as they are the primary facilitators in organ transplantation processes, requiring efficient preservation techniques to enhance organ viability and reduce the risk of rejection.

The growing demand for organ transplants within the Gulf Cooperation Council (GCC) region has led to an increased focus on optimizing preservation techniques. Organ Banks serve as critical repositories for harvested organs, necessitating advanced preservation technologies to maintain organ integrity during storage and transportation.

The collaboration between these End Users is essential for enhancing transplantation rates and improving patient outcomes, thereby driving growth within the GCC Organ Preservation Market. Moreover, increasing awareness about organ donation and supporting legislation in various GCC nations are significant contributors to the evolution of this market. This reflects a commitment to address the organ shortage crisis and promote public health initiatives across the region.

Get more detailed insights about GCC Organ Preservation Market -Forecast to 2035

Request Free Sample

Key Players and Competitive Insights

The GCC Organ Preservation Market is characterized by a dynamic landscape where innovation and strategic positioning dictate competitive advantage. The burgeoning demand for organ transplantation and the critical need for effective preservation techniques have propelled various stakeholders to enhance their capabilities.

Companies within this market are focusing on developing advanced preservation solutions that extend the viability of organs while improving their functional quality. With a rising prevalence of organ transplantation due to chronic diseases and an increasing number of patients requiring such procedures, competition in this sector has become intense.

Organizations are leveraging technology and research collaboration to introduce novel methodologies for organ preservation, which are anticipated to drive market growth significantly.

Bellicum Pharmaceuticals

Bellicum Pharmaceuticals has carved out a notable presence in the GCC Organ Preservation Market through its innovative approach to cellular therapies and organ preservation solutions. The company's strengths lie in its cutting-edge research and development initiatives aimed at optimizing organ preservation methodologies.

Bellicum Pharmaceuticals has established strong channels for collaboration with healthcare institutions and organ transplant centers across the GCC region, showcasing its commitment to advancing preservation technologies. By emphasizing rigorous clinical trials and extensive data analysis, the company enhances its product offerings to better meet the unique needs of healthcare professionals and patients alike.

This rigorous approach solidifies its competitive position in this niche market.

TransMedics

TransMedics has made significant strides in the GCC Organ Preservation Market by introducing advanced organ preservation systems designed to maintain the viability of organs during transportation and transplantation. The company's key products, such as portable organ preservation devices, are engineered to cater specifically to the needs of transplant surgeons in the GCC region, allowing for more successful transplant outcomes.

TransMedics has established a strong market presence through partnerships with leading hospitals and transplant centers, leveraging these relationships to foster acceptance and trust in its technologies. The company's strengths include its focus on innovation, robust clinical evidence supporting its products, and an ongoing commitment to research and development.

Additionally, TransMedics’ strategic mergers and acquisitions have enhanced its capabilities and market reach in the GCC, positioning it as a trusted player in organ preservation solutions.

Key Companies in the GCC Organ Preservation Market market include

Industry Developments

The GCC Organ Preservation Market has witnessed significant developments recently, particularly with technological advancements and increased investments in organ preservation solutions. In September 2023, United Therapeutics announced a collaboration with Xvivo Perfusion to enhance its organ preservation capabilities, focusing on lungs and hearts, which reflects the growing emphasis on improving transplant outcomes.

Furthermore, Bellicum Pharmaceuticals is expanding its portfolio in the region, aligning with local healthcare initiatives to boost organ transplantation efficiency. In terms of market valuation, companies like Thermo Fisher Scientific and LifeNet Health have seen growth, enhancing their product lines and expanding their services to meet rising demands within the GCC healthcare sectors.

Additionally, noteworthy merger and acquisition activities have taken place, notably, in August 2023, Baxter International announced its strategic acquisition of Alliance BioEnergy to strengthen its position within the organ preservation technology space. The ongoing investment in Research and Development by these key players is contributing to the overall dynamism of the GCC Organ Preservation Market, aligning with the region's vision to enhance healthcare services and transplantation effectiveness.

Market Segmentation

Organ Preservation Market End User Outlook

Hospitals & Clinics
Organ Banks

Organ Preservation Market Solution Outlook

University of Wisconsin Solution
Custodial HTK
Collins Solution
Celsior Solution
Perfadex
Citrate Solution

Organ Preservation Market Organ Type Outlook

Kidney
Liver
Heart
Lungs

Organ Preservation Market Preservation Techniques Outlook

Static Cold Storage
Dynamic Cold Storage

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	16.06(USD Million)
MARKET SIZE 2024	17.0(USD Million)
MARKET SIZE 2035	103.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	17.795% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Bellicum Pharmaceuticals, TransMedics, Alliance BioEnergy, Paragonix Technologies, United Therapeutics, Abbott Laboratories, CellTrans, Baxter International, Thermo Fisher Scientific, LifeNet Health, Haemonetics Corporation, Xvivo Perfusion, Celsion Corporation, Organ Recovery Systems, LifeShare
SEGMENTS COVERED	Solution, Preservation Techniques, Organ Type, End User
KEY MARKET OPPORTUNITIES	Growing demand for transplants, Increasing aging population, Advancements in preservation technologies, Rising awareness of organ donation, Government initiatives in healthcare
KEY MARKET DYNAMICS	growing organ transplant demand, increasing healthcare investments, technological advancements in preservation, regulatory compliance and standards, rising awareness of organ donation
COUNTRIES COVERED	GCC

FAQs

What is the expected market size of the GCC Organ Preservation Market in 2024?

The GCC Organ Preservation Market is expected to be valued at 17.0 million USD in 2024.

What is the projected value of the GCC Organ Preservation Market by 2035?

By 2035, the GCC Organ Preservation Market is projected to reach 103.0 million USD.

What is the expected CAGR for the GCC Organ Preservation Market from 2025 to 2035?

The expected CAGR for the GCC Organ Preservation Market from 2025 to 2035 is 17.795%.

Which solution segment is the largest in the GCC Organ Preservation Market?

The University of Wisconsin Solution segment is the largest, valued at 5.0 million USD in 2024.

What will be the market value of the Custodial HTK solution by 2035?

The Custodial HTK solution is projected to be valued at 24.0 million USD by 2035.

Who are the key players in the GCC Organ Preservation Market?

Major players include Bellicum Pharmaceuticals, TransMedics, and Abbott Laboratories among others.

What is the expected growth rate for the Collins Solution segment between 2025 and 2035?

The Collins Solution segment is expected to grow from 3.5 million USD in 2024 to 21.0 million USD by 2035.

How does the Celsior Solution market value change from 2024 to 2035?

The Celsior Solution is expected to increase from 2.5 million USD in 2024 to 15.0 million USD in 2035.

What challenges might impact the GCC Organ Preservation Market in the future?

Challenges may include regulatory hurdles and the need for technological advancements in organ preservation.

What are some emerging trends in the GCC Organ Preservation Market?

Emerging trends include advancements in preservation technologies and increased collaboration among key players.

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027